These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29027706)
21. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults. Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591 [TBL] [Abstract][Full Text] [Related]
22. Regional citrate anticoagulation in membrane based plasma exchange: Safety, efficacy and effect on calcium balance. Christiadi D; Mercado C; Singer R Nephrology (Carlton); 2018 Aug; 23(8):744-747. PubMed ID: 28618127 [TBL] [Abstract][Full Text] [Related]
23. Calcium priming of the central venous catheter prevents a drop in ionized calcium concentration during Regional Citrate Anticoagulation. Roveri G; Busana M; Lusardi AC; Ferrari F; Trevisan G; Di Girolamo L; Dei Poli M; Resta MV ASAIO J; 2019; 65(8):898-901. PubMed ID: 30418191 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of baseline hypocalcemia and symptomatic hypocalcemia during leukapheresis. Bray K; Lynde C; Vu T; Patterson A; Reich RR; Mason TM; Liu HD J Clin Apher; 2023 Dec; 38(6):654-663. PubMed ID: 37522733 [TBL] [Abstract][Full Text] [Related]
29. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility. Wendler T; Lennertz A; Heinemann O; Duhr C; Samtleben W; Bosch T Int J Artif Organs; 2000 Oct; 23(10):710-7. PubMed ID: 11075902 [TBL] [Abstract][Full Text] [Related]
30. Treatment Efficacy and Safety During Plasma Exchange With Citrate Anticoagulation: A Randomized Study of 4 Versus 15% Citrate. Antonic M; Gubensek J; Buturovic-Ponikvar J; Ponikvar R Artif Organs; 2016 Apr; 40(4):368-75. PubMed ID: 26365587 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of pediatric plasma apheresis in intensive care settings. Haque A; Sher G; Hoda M; Moiz B Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients. Hans R; Sharma RR; Marwaha N; Suri D; Kumar R; Gupta A; Singh S J Clin Apher; 2016 Aug; 31(4):381-7. PubMed ID: 26212115 [TBL] [Abstract][Full Text] [Related]
33. A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies. Brandl M; Strobl K; Hartmann J; Kellner K; Posnicek T; Falkenhagen D Blood Purif; 2012; 33(1-3):7-20. PubMed ID: 22085810 [TBL] [Abstract][Full Text] [Related]
34. Complications of apheresis in children. Michon B; Moghrabi A; Winikoff R; Barrette S; Bernstein ML; Champagne J; David M; Duval M; Hume HA; Robitaille N; Bélisle A; Champagne MA Transfusion; 2007 Oct; 47(10):1837-42. PubMed ID: 17880609 [TBL] [Abstract][Full Text] [Related]
35. Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease. Hunt EA; Jain NG; Somers MJ J Clin Apher; 2013 Feb; 28(1):36-47. PubMed ID: 23420594 [TBL] [Abstract][Full Text] [Related]
36. Impairment of citrate metabolism in acute hepatic failure. Apsner R; Schwarzenhofer M; Derfler K; Zauner C; Ratheiser K; Kranz A Wien Klin Wochenschr; 1997 Feb; 109(4):123-7. PubMed ID: 9076929 [TBL] [Abstract][Full Text] [Related]
37. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial. Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168 [TBL] [Abstract][Full Text] [Related]
38. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid. Ong SC; Wille KM; Speer R; Tolwani AJ Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309 [TBL] [Abstract][Full Text] [Related]
39. [How to implement a complete apheresis program within a hemodialysis unit]. Maurizi-Balzan J; Jouve T; Naciri-Bennani H; Noble J; Tanoukhi K; Motte L; Malvezzi P; Rostaing L Nephrol Ther; 2019 Nov; 15(6):439-447. PubMed ID: 31585841 [TBL] [Abstract][Full Text] [Related]